9960 — Kindstar Globalgene Technology Share News
0.000.00%
- HK$933.59m
- -HK$569.48m
- CNY933.57m
Brief: Kindstar Globalgene Technology Posts Full-Year Loss Attributable Of RMB58.7 Million
Brief: Kindstar Globalgene Technology Inc Unit To Buy 40% Of Huaxi Kindstar
Brief: Kindstar Globalgene Technology Expects HY Net Loss Of RMB30-35 Million
Brief: Kindstar Globalgene Technology Sees FY Loss Between RMB55 Million And RMB65 Million
Brief: Kindstar Globalgene Technology Announces New Acquisitions
Brief: Kindstar Globalgene Technology Announces Acquisition Of Stake
Brief: Kindstar Globalgene Technology Inc Says Proposed Acquisition
Brief: Kindstar Globalgene Technology Announces Acquisition Of Property
Brief: Kindstar Globalgene Technology Says No Business Dealings With Silicon Valley Bank
Brief: Kindstar Globalgene Technology Sees Profit Attributable For 1H2022 In Range Of RMB60 Mln To RMB68 Mln
Brief: Kindstar Globalgene Technology Sees Revenue For 1H2022 Within Range Of RMB613 Mln To RMB660 Mln
Brief: Kindstar Globalgene Technology Says From Jan 1 - June 30, CEO Increased Shareholding In Co By Purchasing 804,000 Shares
Brief: Kindstar Globalgene Technology Says Agreed To Make An Investment In Panacea Venture Healthcare Fund II
Brief: Kindstar Globalgene Technology Inc Informed By Chairman Of His Intention To Acquire Shares Of Co
HK-listed Kindstar Globalgene rises most in over 3 months on buyback plan
Brief: Kindstar Globalgene Technology Announces Wuhan Kindstar Medical Laboratory To Buy 1St To 7Th Floors Of A Building Located In Wuhan
Brief: Kindstar Globalgene Tech Inc Says Unit, Ezhou Changda And Gedian Investment And Wuhan Booth Entered Into Partnership Agreement
Brief: Kindstar Globalgene Technology Says Unit To Buy Stake In Xinjiang Kindstar Yijiali Medical Laboratory
Brief: Goldman Sachs Group's Long Position In Kindstar Globalgene Technology Rises To 5.43%- HKEX Filing